AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cartesian Therapeutics, Inc. Director's Dealing 2019

Jul 17, 2019

33483_dirs_2019-07-17_84594ad2-5e13-4595-9487-15d7deb89338.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2019-07-15

Reporting Person: Schecter Alison D. (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-07-15	Common Stock	$1.71	A	350000	Acquired	2029-07-14	Common Stock (350000.0)	Direct

Footnotes

F1: This option vests as to 25% on July 15, 2020, and the remainder of the underlying shares will vest in 36 equal monthly installments thereafter.